Share

October 2016; 6 (5) ResearchOpen Access

Longitudinal change in everyday function and behavioral symptoms in frontotemporal dementia

Claire M. O'Connor, Lindy Clemson, Michael Hornberger, Cristian E. Leyton, John R. Hodges, Olivier Piguet, Eneida Mioshi
First published June 17, 2016, DOI: https://doi.org/10.1212/CPJ.0000000000000264
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2686

Share

Article Information

vol. 6 no. 5 419-428
DOI: 
https://doi.org/10.1212/CPJ.0000000000000264
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received January 29, 2016
  • Accepted April 14, 2016
  • First Published June 17, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Claire M. O'Connor, MOT (Hons),
    2. Lindy Clemson, PhD,
    3. Michael Hornberger, PhD,
    4. Cristian E. Leyton, PhD,
    5. John R. Hodges, MBBS, MD,
    6. Olivier Piguet, PhD and
    7. Eneida Mioshi, PhD
  1. Claire M. O'Connor, MOT (Hons),
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel fellowship from the Alzheimer's Association to attend the 2015 AAIC conference.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Alzheimer's Australia Dementia Research Foundation (AADRF) PhD Scholarship, (2) Mary Frances Stephens Scholarship to support postgraduate research in the discipline of occupational therapy at the University of Sydney, (3) Leslie Rich Scholarship for research into dementia administered by the Sir Zelman Cowen Universities Fund at the University of Sydney.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Lindy Clemson, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Jnl of Ageing and Health, editorial advisory board member, 2012 plus

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHMRC & DoHA Seeding Grant ID 1025006 Clemson L., Gitlin, L., Pizzi, L., Mioshi, E. Jeon, Y-H, Brodaty, H (AI) Black, D. (AI) Tailored activities to reduce challenging behaviours in persons with dementia: A randomized trial of the TAP program August 2012= August 2014 University of Sydney Bridging Grant Clemson, L. Tailored activities to reduce challenging behaviours in persons with dementia 2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Michael Hornberger, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Alzheimer Disease - associate editor Frontier in Aging Neuroscience - section editor No compensation for either role.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Cristian E. Leyton, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associated editor of Journal of Alzheimer's disease since 2015

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. The University of Sydney, Faculty of Health Sciences

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. John R. Hodges, MBBS, MD,
    6. Scientific Advisory Boards:

    1. Member Advisory Board ? Nature Reviews, Neurology - non-profit entity

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Aphasiology (2000 - ) Cognitive Neuropsychology (2002- ) Nature Reviews (2005 - ) Journal of Alzheimer?s Disease, Associate Editor (2010 - ) Acta Neuropsychologica (2011 - ) ALS Journal (2011- ) Neurology and Clinical Neuroscience (NCN) (2013)

    Patents:

    1. NONE

    Publishing Royalties:

    1. OUP, Cognitive Assessment for Clinicians, 2007 CUP, Frontotemporal dementia Syndromes, 2007

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Australian Research Council Federation fellowship, 2007 to 2012 National Health and Medical Research Council of Australia 2007 to 2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Olivier Piguet, PhD and
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Frontiers in Dementia Research, Editorial Board, since 2011 Frontiers in Emotion Science, Editorial Board, since 2011 Behavioural Neurology, Editorial Board, since 2013 Journal of Alzheimer's disease, Editorial Board, since 2015

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) National Health and Medical Research Council of Australia, APP1022684, Career Development Fellowship, 2012-2015 2) National Health and Medical Research Council of Australia, APP1003139, Research Project Grant, 2011-2013 3) Australian Research Council, CE110001021, Centre of Excellence in Cognition and its Disorders, 2011-2017

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Velux Stiftung, Switzerland

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Eneida Mioshi, PhD
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Dementia and Geriatric Cognitive Disorders, Member of the Editorial Board, January 2010 to present. BMC Neurology, Associate Editor (Section Dementias)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHMRC Early Career Fellowship (1016399) 2011-2014

    Research Support, Academic Entities:

    1. Motor Neurone Research Institute of Australia (MNDRIA)

    Research Support, Foundations and Societies:

    1. Alzheimer Society (UK) Alzheimer Association USA (NIRP-12-258380)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Ageing, Work & Health Research Unit (CMO, LC) and Speech Pathology (CEL), Faculty of Health Sciences, University of Sydney, Australia; Faculty of Medicine and Health Sciences (MH, EM), University of East Anglia, UK; Neuroscience Research Australia (CEL, JRH, OP); and ARC Centre of Excellence in Cognition and its Disorders (JRH, OP) and School of Medical Sciences (JRH, OP), University of New South Wales, Australia.
  1. Correspondence to:
    e.mioshi{at}uea.ac.uk

Article usage

Article usage: June 2016 to October 2023

AbstractFullPdfSource
Jun 201613589106Highwire
Jul 20164497106Highwire
Aug 201689133Highwire
Sep 201662030Highwire
Oct 20164402465Highwire
Nov 2016422166181Highwire
Nov 201604522pmc
Dec 2016245129123Highwire
Dec 201605026pmc
Jan 20171454353Highwire
Jan 201703926pmc
Feb 2017119821Highwire
Feb 201703623pmc
Mar 2017110929Highwire
Mar 201702912pmc
Apr 201792820Highwire
Apr 201783029pmc
May 2017571122Highwire
May 201782019pmc
Jun 2017511118Highwire
Jun 201772020pmc
Jul 201746832Highwire
Jul 201721110pmc
Aug 201737827Highwire
Aug 2017141822pmc
Sep 2017221112Highwire
Sep 201771214pmc
Oct 201753210Highwire
Oct 201761717pmc
Nov 201738217Highwire
Nov 201791516pmc
Dec 201701915Highwire
Jan 2018254228Highwire
Feb 2018163730Highwire
Mar 201873823Highwire
Apr 2018243133Highwire
Apr 201871618pmc
May 2018123545Highwire
Jun 201895228Highwire
Jun 201811010pmc
Jul 2018102816Highwire
Aug 201862421Highwire
Aug 201881617pmc
Sep 201862621Highwire
Oct 201882115Highwire
Nov 2018143831Highwire
Dec 201892617Highwire
Jan 201973710Highwire
Feb 201973022Highwire
Mar 2019126239Highwire
Apr 2019103437Highwire
May 2019144020Highwire
Jun 201973117Highwire
Jul 201972720Highwire
Aug 201902824Highwire
Sep 201993018Highwire
Oct 2019164623Highwire
Nov 201984113Highwire
Dec 201984132Highwire
Jan 202054218Highwire
Feb 202074718Highwire
Mar 2020104823Highwire
Apr 202072617Highwire
May 2020114813Highwire
Jun 2020133624Highwire
Jul 202033437Highwire
Aug 202034812Highwire
Sep 2020154527Highwire
Oct 2020165314Highwire
Nov 202083717Highwire
Dec 20201764718Highwire
Jan 202187014Highwire
Feb 2021112330Highwire
Mar 2021152613Highwire
Apr 2021132715Highwire
May 202182819Highwire
Jun 2021102423Highwire
Jul 2021132529Highwire
Aug 2021163318Highwire
Sep 202183216Highwire
Oct 2021134641Highwire
Nov 202161929Highwire
Dec 202110247Highwire
Jan 2022102117Highwire
Feb 20229257Highwire
Mar 2022112823Highwire
Apr 2022143022Highwire
May 2022142425Highwire
Jun 2022121616Highwire
Jul 2022132117Highwire
Aug 202252218Highwire
Sep 2022234124Highwire
Oct 2022153219Highwire
Nov 202276319Highwire
Dec 2022163822Highwire
Jan 2023104618Highwire
Feb 2023104420Highwire
Mar 2023135918Highwire
Apr 2023101711Highwire
May 2023234229Highwire
Jun 202352612Highwire
Jul 20234249Highwire
Aug 2023102618Highwire
Sep 2023102612Highwire
Oct 202393414Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles